These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10858355)

  • 21. Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.
    Entenza JM; Marchetti O; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1889-94. PubMed ID: 9687379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.
    Zhanel GG; Karlowsky JA; Hoban DJ
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):343-7. PubMed ID: 9635908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
    Landman D; Quale JM; Mobarakai N; Zaman MM
    J Antimicrob Chemother; 1995 Jul; 36(1):253-8. PubMed ID: 8537276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
    López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
    J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Cha R; Rybak MJ
    Diagn Microbiol Infect Dis; 2003 Nov; 47(3):539-46. PubMed ID: 14596973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Perronne CM; Malinverni R; Glauser MP
    Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.
    Tripodi MF; Locatelli A; Adinolfi LE; Andreana A; Utili R
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):734-6. PubMed ID: 9865990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure.
    Peterson ML; Hovde LB; Wright DH; Hoang AD; Raddatz JK; Boysen PJ; Rotschafer JC
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2251-5. PubMed ID: 10471574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
    Bonilla HF; Zarins LT; Bradley SF; Kauffman CA
    Diagn Microbiol Infect Dis; 1996 Sep; 26(1):17-21. PubMed ID: 8950524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis.
    Kaatz GW; Barriere SL; Schaberg DR; Fekety R
    J Antimicrob Chemother; 1987 Nov; 20(5):753-8. PubMed ID: 3429376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
    Jones ME; Visser MR; Klootwijk M; Heisig P; Verhoef J; Schmitz FJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):421-3. PubMed ID: 9925551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci.
    Cohen MA; Yoder SL; Huband MD; Roland GE; Courtney CL
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2123-7. PubMed ID: 8540728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
    Bauernfeind A
    J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.
    Firsov AA; Vostrov SN; Kononenko OV; Zinner SH; Portnoy YA
    Antimicrob Agents Chemother; 1999 Mar; 43(3):498-502. PubMed ID: 10049257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW; Barriere SL; Schaberg DR; Fekety R
    Antimicrob Agents Chemother; 1987 Apr; 31(4):527-30. PubMed ID: 3649202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci.
    Perri MB; Chow JW; Zervos MJ
    Diagn Microbiol Infect Dis; 1993; 17(2):151-5. PubMed ID: 8243036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
    Werth BJ; Shireman LM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin.
    Quale JM; Landman D; Mobarakai N
    J Antimicrob Chemother; 1994 Nov; 34(5):797-802. PubMed ID: 7706176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.